Anti-leprosy vaccines--field trials and future prospects.
作者信息
Deo M G
出版信息
Indian J Lepr. 1984 Oct-Dec;56(4):764-75.
PMID:6442720
Abstract
Development of a vaccine for prevention of leprosy is today one of the major challenges for bio-medical sciences. Two vaccines containing (i) M. leprae + BCG and (ii) ICRC, a cultivable mycobacterium, have reached advanced stage with reference to human trials. This article describes comparative features of two vaccines and mechanism of their action. Future possibilities with reference to anti-leprosy vaccine are also discussed.
摘要
相似文献
1
Anti-leprosy vaccines--field trials and future prospects.
Indian J Lepr. 1984 Oct-Dec;56(4):764-75.
2
Antigeneic cross-reactivity between ICRC-bacilli and M. leprae--"in vitro" evaluation.
Indian J Lepr. 1984 Apr-Jun;56(2):219-31.
3
Immunization against leprosy: progress and prospects.麻风病免疫接种：进展与前景。
Bull World Health Organ. 1984;62(1):1-6.
4
Induction of delayed-type hypersensitivity by ICRC anti-leprosy vaccine and the adoptive transfer of cell-mediated immunity in mice.
Indian J Lepr. 1984 Oct-Dec;56(4):754-63.
5
Rationales for vaccines against leprosy.
Int J Lepr Other Mycobact Dis. 1983 Dec;51(4):505-9.
6
The cellular and molecular basis of immunity against mycobacterial diseases.
Soc Appl Bacteriol Symp Ser. 1996;25:33S-39S.
7
Anti-leprosy vaccines: current status and future prospects.
J Postgrad Med. 1991 Oct;37(4):198-204.
8
Immunotherapy and immunoprophylaxis of leprosy.
Indian J Lepr. 2000 Jan-Mar;72(1):21-32.
9
Immunosuppression and cellular immunity reactions in leprosy patients treated with a mixture of Mycobacterium leprae and BCG.
Int J Lepr Other Mycobact Dis. 1987 Dec;55(4):646-50.
10
Leprosy vaccine--a puzzle.
Lepr India. 1983 Jan;55(1):1-7.
引用本文的文献
1
Mycobacterium indicus pranii and Mycobacterium bovis BCG lead to differential macrophage activation in Toll-like receptor-dependent manner.印度斯坦分枝杆菌和牛分枝杆菌卡介苗以Toll样受体依赖的方式导致不同的巨噬细胞活化。
Immunology. 2014 Oct;143(2):258-68. doi: 10.1111/imm.12306.
Zotero 插件